IL324233A - הרכבים המכילים קונסורציום של חיידקים - Google Patents

הרכבים המכילים קונסורציום של חיידקים

Info

Publication number
IL324233A
IL324233A IL324233A IL32423325A IL324233A IL 324233 A IL324233 A IL 324233A IL 324233 A IL324233 A IL 324233A IL 32423325 A IL32423325 A IL 32423325A IL 324233 A IL324233 A IL 324233A
Authority
IL
Israel
Prior art keywords
dsm
bacterial strain
atcc
jcm
bacteroides
Prior art date
Application number
IL324233A
Other languages
English (en)
Original Assignee
Pharmabiome Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmabiome Ag filed Critical Pharmabiome Ag
Publication of IL324233A publication Critical patent/IL324233A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/62—Carboxylic acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Biotechnology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL324233A 2023-04-28 2025-10-26 הרכבים המכילים קונסורציום של חיידקים IL324233A (he)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP23170659 2023-04-28
EP23207180 2023-10-31
PCT/EP2024/061647 WO2024223885A1 (en) 2023-04-28 2024-04-26 Compositions comprising bacteria consortia

Publications (1)

Publication Number Publication Date
IL324233A true IL324233A (he) 2025-12-01

Family

ID=90924206

Family Applications (1)

Application Number Title Priority Date Filing Date
IL324233A IL324233A (he) 2023-04-28 2025-10-26 הרכבים המכילים קונסורציום של חיידקים

Country Status (8)

Country Link
EP (1) EP4701644A1 (he)
JP (1) JP2026515014A (he)
KR (1) KR20260005331A (he)
CN (1) CN121175058A (he)
AU (1) AU2024260979A1 (he)
IL (1) IL324233A (he)
MX (1) MX2025012889A (he)
WO (1) WO2024223885A1 (he)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119432677B (zh) * 2024-12-19 2025-05-27 西北农林科技大学 一株能够提高反刍动物产奶量及乳脂率的布氏普氏菌b14及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3388069B1 (en) 2017-04-12 2019-05-01 ETH Zurich Consortia of living bacteria useful for treatment of microbiome dysbiosis
WO2019046372A1 (en) * 2017-08-31 2019-03-07 The Regents Of The University Of Michigan COMPOSITIONS AND METHODS FOR INCREASING BUTYRATE PRODUCTION
WO2020079021A1 (en) * 2018-10-15 2020-04-23 Pharmabiome Ag Consortia of living bacteria useful for treatment of cancer related diseases, particularly graft versus host disease
IL328606A (he) 2018-10-15 2026-07-01 Pharmabiome Ag שיטת ייצור של קונסורציום של זנים בקטריאליים
CN113795155A (zh) * 2019-05-01 2021-12-14 宝洁公司 产生短链脂肪酸的益生菌菌株和包含该益生菌菌株的组合物
WO2021074239A1 (en) * 2019-10-15 2021-04-22 Pharmabiome Ag Use of glycerol for increasing butyrate production by bacteria in a consortium
CA3188645A1 (en) * 2020-08-14 2022-02-17 Prolacta Bioscience, Inc. Human milk oligosaccharide compositions for use with bacteriotherapies

Also Published As

Publication number Publication date
MX2025012889A (es) 2025-12-01
EP4701644A1 (en) 2026-03-04
KR20260005331A (ko) 2026-01-09
WO2024223885A1 (en) 2024-10-31
CN121175058A (zh) 2025-12-19
AU2024260979A1 (en) 2025-11-13
JP2026515014A (ja) 2026-05-13

Similar Documents

Publication Publication Date Title
US12390498B2 (en) Treatment of clostridium difficile infection
JP7409743B2 (ja) 病原性細菌生育の抑制のための組成物および方法
JP7460979B2 (ja) ヒトおよび動物の健康ための微生物コミュニティーの使用
JP2024038027A (ja) 相乗作用のある細菌組成物ならびにその製造及び使用方法
Warda et al. A postbiotic consisting of heat-treated lactobacilli has a bifidogenic effect in pure culture and in human fermented fecal communities
US20210355431A1 (en) Method of manufacturing a consortium of bacterial strains
EP2522358A1 (en) Peptides against rotavirus infection
EE201800005A (et) Probiootilist mikroorganismi tüve Lactobacillus plantarum Inducia DSM 21379 sisaldav kompositsioon kasutamiseks Clostrdium difficile põhjustatud kõhulahtisuse (CDAD) riski vähendamiseks
CN103491969A (zh) 恢复和重建肠道微生物群的合生素组合物
US20220409674A1 (en) Compositions and methods for suppressing pathogenic organisms
WO2024191890A2 (en) Microbial consortia
US20250082695A1 (en) Use of glycerol for increasing butyrate production by bacteria in a consortium
US20240082321A1 (en) Stimulation of the growth of gut bifidobacteria
EE05799B1 (et) Hüpokolestereemilist probiootilist mikroorganismi tüve Lactobacillus plantarum Inducia DSM 21379 sisaldav kompositsioon kasutamiseks südame-veresoonkonnahaiguste ennetamiseks
AU2024260979A1 (en) Compositions comprising bacteria consortia
Malaviya et al. Saccharomyces-Eukaryotic probiotic for human applications
EP4739145A1 (en) Method for establishing a combination therapy and corresponding pharmaceutical and nutritional combinations
US20260007704A1 (en) Microbial consortia
HK40104391A (en) Treatment of clostridium difficile infection
WO2025076184A1 (en) Methods of decreasing dysbiosis and restoring a microbiome